Press Releases

All Releases
Jan 31, 2012
AngioDynamics to Acquire Navilyst Medical for $372 Million
AngioDynamics to host conference call today at 11:30 am ET Increases Scale in Vascular Access and Peripheral Vascular Markets Expands Product Portfolio and Adds Innovative Technologies Strengthens Focus on Operational Excellence Expected to be Accretive in FY13 ALBANY, N.Y. and MARLBOROUGH, Mass.
Jan 24, 2012
AngioDynamics Updates Financial Guidance for Fiscal Year 2012
Company Implements Voluntary Recall of Ablation Zone Estimator Software on NanoKnife ® Systems Installed in the U.S. Resumption of NeverTouch ® Procedure Kit Shipments Leads to Better Than Expected Demand ALBANY, N.Y. , Jan. 24, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a
Jan 05, 2012
AngioDynamics Reports Fiscal 2012 Second Quarter Financial Results
ALBANY, N.Y. , Jan. 5, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial results for the fiscal 2012 second quarter ended
Nov 08, 2011
AngioDynamics Expands Senior Leadership Team
ALBANY, N.Y. , Nov. 8, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, appointed Matthew Kapusta , Senior Vice President of Business Development,
Oct 06, 2011
AngioDynamics Reports Fiscal 2012 First Quarter Financial Results
Results Meet Company Guidance; Management Reiterates Full Fiscal Year Guidance Authorizes Stock Repurchase Program ALBANY, N.Y. , Oct. 6, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery,
Sep 22, 2011
Scott Solano to Depart AngioDynamics
ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced that Scott Solano , Senior Vice President and Chief Technology Officer, has resigned
Sep 12, 2011
AngioDynamics Names Alan Panzer SVP, GM of Vascular Division
ALBANY, N.Y. , Sept. 12, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, has appointed Alan Panzer , 50, as Senior Vice President and General Manager of
Aug 16, 2011
AngioDynamics Names Joseph M. DeVivo President and CEO
ALBANY, N.Y. --(BUSINESS WIRE)-- The Board of Directors of AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, appointed Joseph M. DeVivo President and Chief Executive Officer,
Displaying 261 - 280 of 700